410 related articles for article (PubMed ID: 15458816)
21. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
23. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
[TBL] [Abstract][Full Text] [Related]
24. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
25. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.
Spingler B; Whittington DA; Lippard SJ
Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959
[TBL] [Abstract][Full Text] [Related]
26. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
Ahmad S
Chem Biodivers; 2010 Mar; 7(3):543-66. PubMed ID: 20232326
[TBL] [Abstract][Full Text] [Related]
27. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
Zhu G; Chang P; Lippard SJ
Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
[TBL] [Abstract][Full Text] [Related]
28. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
29. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin.
Scheeff ED; Briggs JM; Howell SB
Mol Pharmacol; 1999 Sep; 56(3):633-43. PubMed ID: 10462551
[TBL] [Abstract][Full Text] [Related]
30. Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.
Malina J; Novakova O; Vojtiskova M; Natile G; Brabec V
Biophys J; 2007 Dec; 93(11):3950-62. PubMed ID: 17704160
[TBL] [Abstract][Full Text] [Related]
31. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
Ouzon-Shubeita H; Baker M; Koag MC; Lee S
Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
[TBL] [Abstract][Full Text] [Related]
33. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
34. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
[TBL] [Abstract][Full Text] [Related]
35. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
36. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
Ang WH; Myint M; Lippard SJ
J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells.
Rietbroek RC; van de Vaart PJ; Haveman J; Blommaert FA; Geerdink A; Bakker PJ; Veenhof CH
J Cancer Res Clin Oncol; 1997; 123(1):6-12. PubMed ID: 8996534
[TBL] [Abstract][Full Text] [Related]
38. MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.
Zdraveski ZZ; Mello JA; Farinelli CK; Essigmann JM; Marinus MG
J Biol Chem; 2002 Jan; 277(2):1255-60. PubMed ID: 11705991
[TBL] [Abstract][Full Text] [Related]
39. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
Zhu G; Myint M; Ang WH; Song L; Lippard SJ
Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
[TBL] [Abstract][Full Text] [Related]
40. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
Jung Y; Lippard SJ
J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
